- menu
aminos
sprays
peptides
liquids
- all categories
Semaglutide / Cagrilintide Blend combines a GLP-1 receptor agonist (Semaglutide) with an amylin analog (Cagrilintide) to target multiple pathways in appetite regulation and metabolic control. Research suggests this pairing may enhance satiety, reduce food intake, slow gastric emptying, and promote significant weight loss while improving glucose tolerance and supporting cardiovascular health.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. HEALTHTEKLAB is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act.
